Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells

12 Apr 2010

Abstract excerpt

The potential of mesenchymal stem cells (MSC) to differentiate into functional bone forming cells provides an important tool for bone regeneration. The identification of factors capable of promoting osteoblast differentiation in MSCs is therefore critical to enhance the osteogenic potential of MSCs. Using microarray analysis combined with biochemical and molecular approach, we found that FGF18, a member of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Fibroblast Growth Factor Research
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20432451
DOI: 10.1002/jcp.22152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cellsPMID 20432451Read ↗

Modulation of ossification and inflammatory pathways during dexamethasone-induced <i>in vitro</i> osteogenesisSemantic proximity Read ↗

Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesisSemantic proximity Read ↗

FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cellsSemantic proximity Read ↗

Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiationSemantic proximity Read ↗

FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis.Semantic proximity Read ↗

FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.Semantic proximity Read ↗

Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.Semantic proximity Read ↗

Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow‐Derived Mesenchymal Stem CellsSemantic proximity Read ↗

Insulin-like Growth Factor-I Induces Early Osteoblast Gene Expression in Human Mesenchymal Stem CellsSemantic proximity Read ↗

Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosisSemantic proximity Read ↗

Osteogenic Differentiation of Recombinant Adeno-Associated Virus 2-Transduced Murine Mesenchymal Stem Cells and Development of an Immunocompetent Mouse Model for Ex Vivo Osteoporosis Gene TherapySemantic proximity Read ↗

Enhancement of BMP-2-Induced Osteogenic Differentiation of MC3T3-E1 Cells by Dexamethasone through the Smad Signaling PathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.